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(i) The major sites on bovine adrenal tyrosine hydroxylase (TH) phosphorylated by calmodulindependent multiprotein 
kinase (CaM-MPK) and cyclic AMP-dependent protein kinase were shown to be Ser-19 and Ser-40, respectively, while 
Ser-40 was also phosphorylated slowly by CaM-MPK. (ii) Type 2A and type 2C phosphatases accounted for ~90% and 
z lm of TH phosphatase activity, respectively, in extracts of adrenal medulla and corpus striatum assayed at near phy- 
siological free M@+(l mM), while type 1 and type 2B phosphatases had negligible activity towards TH. (iii) Incubation 
of adrenal chromatBn cells with okadaic acid increased TH phosphorylation by 206% and activity by 775, establishing 
that type 2A phosphatases play a major role in regulating TH in vivo. 
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1. INTRODUCTION 
Tyrosine 3-monooxygenase (tyrosine hydrox- 
ylase (TH); EC 1.14.16.2), the rate-limiting en- 
zyme in catecholamine biosynthesis [l], is mainly 
located in the adrenal medulla and brain, where it 
is enriched in the striatum. The enzyme is 
phosphorylated and activated by a variety of pro- 
tein kinases in vitro, including cyclic AMP- 
dependent protein kinase (A-kinase), calmodulin- 
dependent multiprotein kinase (CaM-MPK), pro- 
tein kinase C, and less well defined kinases 
associated with purified TH (reviewed in [2]). 
Three phosphorylation sites have been identified in 
TH from rat pheochromocytoma (an adrenal 
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tumour). Serine 8 is labelled by a protein kinase 
that contaminates purified TH, Ser-19 by CaM- 
MPK and Ser40 by A-kinase [3]. Ser-40 is also 
phosphorylated by CaM-MPK, although at a 
lower rate than Ser-19. TH is multiply 
phosphorylated in adrenal chromaffin cells [4,5], 
brain [a] and PC12 pheochromocytoma cells [7] 
and phosphorylation increases in response to a 
variety of agonists, such as acetylcholine, K+ 
depolarisation, cyclic AMP analogues or phorbol 
esters (reviewed in [2]). However, the precise sites 
phosphorylated in vivo have still to be defined. 
Very little is known about the protein 
phosphatases that dephosphorylate TH. Yamauchi 
and Fujisawa [8] found that TH activity in cytosol 
of bovine adrenal medulla was inhibited by sodium 
phosphate and fluoride and stimulated by Mg’+, 
while Nelson and Kaufman [9] resolved three 
peaks of TH phosphatase activity after 
chromatographing extracts of rat caudate nucleus 
on DEAE cellulose. A peak eluting at 0.3 M NaCl 
was the only one which dephosphorylated TH 
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phosphorylated by A-kinase and the major one 
which dephosphorylated TH labelled by CaM- 
MPK. Two further peaks with activity towards TH 
phosphorylated by CaM-MPK were eluted at lower 
NaCl and reported to be inhibited by 1 mM Ca2+ 
[91. 
Large quantities of homogeneous tyrosine 
hydroxylase from bovine adrenal medulla have 
recently become available [lo], sufficient for mak- 
32 ing the P- labelled enzyme needed to identify the 
sites of phosphorylation and to characterise TH 
phosphatases. In this paper, we identify the 
residues phosphorylated by A-kinase and CaM- 
MPK in vitro, and use an improved procedure 
based on the tumour promoter okadaic acid to 
identify the protein phosphatases which dephos- 
phorylate TH in vitro and in intact chromaffin 
cells. 
2. EXPERIMENTAL 
2.1. Materials 
TH was purified from bovine adrenal cytosol [lo] and the 
catalytic subunits of protein phosphatases 1and 2A from rabbit 
skeletal muscle [ll]. The catalytic subunit of A-kinase from 
bovine heart [12] (Dr C. Smythe), CaM-MPK from rat brain 
1131 (Dr D.G. Hardie) and inhibitors 1 and 2 from rabbit 
skeletal muscle [I41 (Dr M.J. Hubbard) were provided by other 
members of the Dundee laboratory. Okadaic acid was obtained 
from Dr Y. Tsukitani (Fujisawa Chemical Company, Japan). 
2.2. Preparation of tissue extracts 
Bovine skeletal muscle and adrenal glands were obtained 
from the local abattoir after about 30 min of warm ischemia, 
and transported to the laboratory on ice. The adrenal cortex 
and medulla were dissected and these tissues and rabbit corpus 
striatum homogenized in a Potter-Elvehjem homogenizer in 
3 vol. of ice cold buffer containing 50 mM Tris-HCI, pH 7.0, 
2 mM EDTA, 2 mM EGTA, 0.1 mM phenylmethylsulphonyl 
fluoride, 1 mM benzamidine and 250 mM sucrose. The 
homogenates were centrifuged for 10 min at 1000 x g, and the 
supernatants removed and centrifuged for 17 min at 15000 x g. 
The supernatant was removed and the pellet resuspended in the 
same volume of homogenizing buffer. Contamination of 
adrenal medulla by adrenal cortex and vice versa was ~5%. 
Bovine skeletal muscle was minced and homogenized in a War- 
ing blender for 30 s at low speed using the same buffer except 
that sucrose was omitted. After centrifugation for 45 min at 
4200 x g, the supernatant was decanted. 
2.3. Isolation and labelling of chromaffin cell 
Bovine adrenal chromaffin cells were isolated essentially as 
described [15] and kept in a buffer containing 20 mM Hepes, 
pH 7.2, 130 mM NaCl, 10 mM KCl, 2.2 mM CaClr and 5 mM 
glucose. Typically, cell viability was greater than 90%, as 
judged by trypan blue exclusion. The cells (3.4 x 106/ml) were 
incubated for 90 min at 37°C in [‘*PIphosphate (0.2 mCi/ml) 
and 1 PM okadaic acid, then pelleted rapidly and homogenized 
in 10 vols of ice cold 25 mM EDTA, 25 mM EGTA, 40 mM 
sodium fluoride, 5 mM sodium pyrophosphate and 0.1 mg/ml 
leupeptin, pH 7.0. The homogenate was divided into three por- 
tions. One was precipitated with 10% (w/v) trichloroacetic acid 
to measure total ‘*P-incorporation into protein; the second was 
used to measure TH activity, while the third was mixed with an 
equal volume of 1% SDS, incubated for 10 min at 95”C, sub- 
jected to SDS-polyacrylamide gel electrophoresis and 
autoradiographed. TH phosphorylation was’ then estimated by 
densitometric scanning of the 60 kDa band on the 
autoradiograms. 
2.4. Preparation of 32P-labelied protein substrates 
These were prepared with a specific activity of 
lo6 dpm/nmol. ‘ZP-labelled bovine adrenal TH was 
phosphorylated to 0.4-0.6 mo1/60 kDa subunit using A-kinase 
or 0.5 mol phosphate/60 kDa subunit using CaM-MPK [3] and 
freed from [y-“P]ATP by gel filtration on Sephadex G50 at 
ambient temperature as in [la]. Since some preparations of TH 
contained significant amounts of endogenous protein 
phosphatase 2A activity, the 32P-labelled enzyme was incubated 
for 15 min at ambient temperature in the presence of 50 mM 
NaF and 10 mM sodium pyrophosphate prior to gel filtration. 
After this treatment, the phosphorylated enzyme could be 
stored for one week at 5°C with little loss of “‘P-radioactivity. 
32P-labelled phosphorylase (1 mol phosphate/97 kDa subunit) 
1111 and 32P-labelled phosphorylase kinase (1.8 mol 
phosphate/a&& unit) [16] (both from rabbit muscle) were 
prepared by phosphorylation with phosphorylase kinase and A- 
kinase, respectively. 
2.5. Protein phosphatase assay 
Protein phosphatases were assayed in the absence of divalent 
cations and presence of 0.1 mM EGTA as in [I 1,161, although 
20 mM magnesium acetate was included to measure type 2C ac- 
tivity where indicated 1171. Caffeine (5 mM) was included when 
glycogen phosphorylase was the substrate [111. When inhibitors 
1 or 2 were present, diluted enzyme was preincubated for 
15 min with inhibitor prior to initiating reactions with substrate 
U41. 
2.6. Assay of tyrosine hydroxylase activity 
This was measured in potassium-Mes buffers at pH 6.0 and 
7.0 [18] using 0.1 mM L-tyrosine as substrate and 1 mM 
6-methyl-tetrahydropterin ascofactor. 
2.7. Isolation of phosphopeptides and sequence analysis 
Native 32P-labelled tyrosine hydroxylase was cleaved with 
trypsin to release trichloroacetic acid-soluble phosphopeptides, 
which were chromatographed on a Vydac Cl8 column (The 
Separations Group, Hesperia, CA, USA) equilibrated in 0.1% 
trifluoroacetic acid as in [3]. The major peptide phosphorylated 
by CaM-MPK was pure, but that phosphorylated by A-kinase 
required further chromatography on the Vydac column in am- 
monium acetate at pH 6.5 before sequence analysis [3]. The 
peptides were analysed on an Applied Biosystems 470A gas- 
phase sequencer. 
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3. RESULTS AND DISCUSSION 
3.1. Identification of phosphorylation sites on 
bovine adrenal tyrosine hydroxylase 
After phosphorylation by either A-kinase or 
CaM-MPK, over 90% of the 32P-radioactivity was 
released from bovine adrenal TH as trichloroacetic 
acid-soluble peptides by brief tryptic digestion of 
the native enzyme, as observed previously for rat 
pheochromocytoma tyrosine hydroxylase. All the 
32P-radioactivity was present as phosphoserine, as 
judged by electrophoresis on thin layer cellulose at 
pH 1.9 following partial acid hydrolysis (not 
shown). One major phosphopeptide (peptide A) 
was obtained after phosphorylation by A-kinase 
eluting from the Cr8 column at 15% acetonitrile 
(fig. l), while two phosphopeptides were obtained 
after phosphorylation by CaM-MPK. The major 
peptide labelled by CaM-MPK (peptide C) eluted 
at 13% acetonitrile, while the minor coeluted with 
peptide A (fig.1). 
The SeqUtX-ICe Of peptide A WaS &9Q74%3L42140- 
Q37DuA&+, while that of peptide C was 
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Fig. 1. Reverse-phase chromatography of tryptic phosphopep- 
tides (A-C) from bovine adrenal TH. Chromatography was in 
0.1% (by vol.) trifluoroacetic acid and developed with an 
acetonitrile gradient (broken line). The full line shows 32P- 
radioactivity in arbitrary units determined with an on-line 
monitor. The upper and lower traces show tryptic peptides 
obtained from TH phosphorylated by the CaM-MPK and A- 
kinase, respectively. The radioactivity in the flowthrough 
fractions is free ATP. The closed circles show the positions of 
the phosphorylated serines. 
subscripts denote pmol of phenylthiohydantoin 
amino acids detected after each cycle of Edman 
degradation in the gas-phase sequencer. These se- 
quences correspond to residues 38-46 and 17-24 
of the predicted structure of bovine adrenal 
tyrosine hydroxylase deduced from the cDNA 
[3,10,19,20], and each differ at one position from 
the sequences urrounding Ser40 and Ser-19 of the 
pheochromocytoma enzyme (the second glutamine 
in peptide A being replaced by glutamic acid, and 
the leucine residue in peptide C by glutamine) [3]. 
The results demonstrate that A-kinase and CaM- 
MPK phosphorylate the equivalent residues in the 
bovine adrenal and rat pheochromocytoma 
tyrosine hydroxylases. 
Purified bovine adrenal tyrosine hydroxylase 
contained variable amounts of an endogenous 
tyrosine hydroxylase kinase activity, which could 
be inhibited completely by the specific protein in- 
hibitor of A-kinase (not shown), indicating that it 
is the catalytic subunit of A-kinase. 
3.2. Identification of the major tyrosine 
hydroxylase phosphatases in extracts of 
adrenal medulla and corpus striatum 
Four major types of serine/threonine-specific 
protein phosphatases account for all the 
phosphatase activity in a variety of mammalian 
tissues towards a number of phosphoproteins 
(reviewed in [21]), and improved procedures for 
identifying and quantitating these enzymes in 
tissue extracts have been developed recently [22]. 
Type 1 and type 2A protein phosphatases are ac- 
tive in the absence of divalent cations and can be 
inhibited specifically by 0.2 PM inhibitor 1 or in- 
hibitor 2 (type 1) and 2 nM okadaic acid (type 2A), 
respectively. Type 2B (a Ca*+-dependent, 
calmodulin-stimulated phosphatase) is inhibited by 
EGTA or trifluoperazine, while type 2C (a 
Mg*+-dependent phosphatase insensitive to 
okadaic acid) can be measured specifically in 
assays containing EGTA and micromolar okadaic 
acid (which inactivates type 1 as well as type 2A 
phosphatases). 
In the absence of divalent cations and presence 
of EGTA about 90% of the phosphorylase 
phosphatase activity in extracts of bovine adrenal 
medulla or adrenal cortex was catalysed by type 2A 
phosphatases and only 10% by type 1 
phosphatases, as indicated by the percentage of ac- 
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Table 1 
Effect of inhibitor-2, okadaic acid and magnesium ions on phosphorylase phosphatase (PhP) and tyrosine hydroxylase 
phosphatase (THP) activities in extracts of bovine adrenal medulla, adrenal cortex and skeletal muscle, and rabbit corpus 
striatum 
Additions Adrenal medulla Adrenal cortex Corpus striatum Skeletal muscle 
PhP THP PhP THP PhP THP PhP 
activity activity activity activity activity activity activity 
(To) (To) (%) (%) (Q) (o/o) (070) 
1. None 100 100 100 100 100 100 100 
2. Okadaic acid (2 nM) 10 * 2 6+2 10 + 2 3+2 39 * 1 6+1 77 f 3 
3. Inhibitor-2 (0.2 PM) 89 z+ 2 96 + 3 86 f 3 98 f 2 61 + 4 97 t 1 18 f 1 
4. Okadaic acid (2 nM) 
plus inhibitor-2 (0.2 PM) 3+1 2+1 3+1 2+1 4*1 2+1 2fl 
5. Okadaic acid (5 PM) <l 0 0 0 <l 0 0 
6. Okadaic acid (5 PM) 
plus 20 mM Mg2+ - 28 + 3 _ 24 + 2 _ 17 * 2 _ 
Assays were carried out at 1:300 dilution of each extract (1:600 for muscle) using 10 PM “P-1abelled phosphorylase 
(phosphorylated by phosphorylase kinase) or 1 PM 3ZP-labelled tyrosine hydroxylase (phosphorylated by A-kinase). Values 
are given relative to those measured in the standard assay (EGTA without Mg2+) f standard error for at least three 
determinations on two preparations. 100% values were: phosphorylase phosphatase, 0.75 f 0.02 mU/mg (adrenal 
medulla), 1.4 + 0.2 mU/mg (adrenal cortex), 5.3 + 0.9 mU/mg (corpus striatum), 5.5 + 0.3 mU/mg (skeletal muscle); 
tyrosine hydroxylase phosphatase, 0.14 + 0.01 mU/mg (adrenal medulla), 0.22 + 0.02 mU/mg (adrenal cortex), 0.47 e 
0.03 mU/mg (corpus striatum). One unit of activity is that amount which catalyses the release of 1 ymol of phosphate in 
1 min. Very similar results were obtained when inhibitor-2 was replaced by inhibitor-l 
tivity inhibited by either 2 nM okadaic acid or 
0.2 PM inhibitor 2 (table 1). This type 2A/type 1 
ratio of 10: 1 with phosphorylase as substrate was 
about 6-fold higher than in extracts of rabbit cor- 
pus striatum and 40-fold higher than in extracts of 
bovine skeletal muscle where type 1 phosphatases 
were predominant (table 1). Phosphorylase phos- 
phatase activity was almost completely abolished 
by the addition of both 2 nM okadaic acid and 
0.2 PM inhibitor 2, indicating that type 1 and type 
2A phosphatases account for virtually all the ac- 
tivity towards this substrate in each tissue (table 1). 
The high proportion of type 2A activity in bovine 
adrenal medulla and cortex was confirmed by the 
finding that these extracts dephosphorylated the CY- 
subunit of phosphorylase kinase much more rapid- 
ly than the&subunit, and by the finding that near- 
ly all the activity was excluded from heparin- 
Sepharose [23] (not shown). 
When TH (phosphorylated by A-kinase) was 
used instead of phosphorylase almost all the activi- 
ty in bovine adrenal medulla and adrenal cortex 
(table l), rabbit adrenal gland (not shown) or cor- 
pus striatum (table 1) was inhibited by 2 nM 
okadaic acid, and inhibitor 2 had virtually no ef- 
fect, demonstrating that type 2A phosphatases ac- 
count for almost all the TH phosphatase activity 
under these assay conditions. This was confirmed 
by the finding that virtually all the TH 
phosphatase activity in adrenal medullary extracts 
was excluded from heparin-Sepharose (not 
shown). Experiments with the purified catalytic 
subunits of protein phosphatase 1 and protein 
phosphatase 2A from rabbit skeletal muscle, 
demonstrated that type 1 had a 40-fold higher 
phosphorylase phosphatase/TH phosphatase ac- 
tivity ratio than type 2A (not shown), explaining 
the results in table 1. Homogeneous preparations 
of the catalytic subunit of protein phosphatase 2A 
had a similar phosphorylase phosphatase/TH 
phosphatase activity ratio to that observed in ex- 
tracts of adrenal medulla (not shown). The weak 
TH phosphatase activity of the pure catalytic 
subunit of protein phosphatase 1 could be in- 
hibited completely by 0.2 pM inhibitor 1 or in- 
hibitor 2, demonstrating that it was catalysed by 
this enzyme and not by traces of contaminating 
protein phosphatase 2A. 
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Fig.2. Effect of okadaic acid on the inhibitor-2 insensitive 
phosphorylase phosphatase and tyrosine hydroxylase 
phosphatase activities in extracts of bovine adrenal medulla and 
rabbit corpus striatum. Assays were carried out at a 300-fold 
final dilution of the extracts in the presence of inhibitor 2. The 
circles show phosphory!ase phosphatase and the triangles 
tyrosine hydroxylase phosphatase activity. Experiments with 
adrenal extracts are shown by the open symbols and 
experiments with striatal extracts by the filled symbols. 
The amount of okadaic acid required to inhibit 
the catalytic subunit of protein phosphatase 2A is 
similar to the phosphatase concentration in the 
assays, and the ICSO therefore depends on the con- 
centration of this enzyme in the assays [22]. When 
extracts of adrenal medulla and basal ganglion 
were diluted 300-fold to give a phosphorylase 
phosphatase activity of CO. 1 mu/ml, the 
dephosphorylation of this substrate was inhibited 
with an ICSO of about 0.1 nM, as expected [22]. 
The ICSO for okadaic acid with TH as substrate was 
0.2 nM (fig.2). 
In the presence of 5 /IM okadaic acid, the TH 
phosphatase activity in adrenal medulla, adrenal 
cortex and corpus striatum was completely depen- 
dent on Mg2+, indicating that type 2C protein 
phosphatases are active towards TH (table 1). 
However, TH phosphatase activity catalysed by 
type 2A phosphatases was 3.6-fold (adrenal 
medulla) and 6-fold (corpus striatum) greater than 
that catalysed by type 2C enzymes at optimal Mg2+ 
(20 mM). Since the concentration of Mg2+ which 
half maximally activates the TH phosphatase ac- 
tivity of type 2C phosphatases in each extract is 
1 mM (not shown), type 2C only accounts for 11% 
and 7% of the total TH phosphatase activity in 
dilute extracts of adrenal medulla and corpus 
striatum, respectively, at near physiological free 
Mg2+ (about 1 mM). Omission of EGTA and in- 
clusion of 0.2 mM CaCl2 did not alter TH 
phosphatase activity significantly, while trifluoper- 
azine (150 /IM) had no effect, indicating that type 
2B phosphatases do not contribute significantly to 
TH phosphatase activity in the extracts (not 
shown). Inclusion of tetrahydrobiopterin (0.1-3 
mM) in the assays had no effect on the TH 
phosphatase activity of the extracts. 
Table 2 
Effect of treating intact chromaffin cells with okadaic acid (1 ,uM) on tyrosine hydroxylase 
activity and phosphorylation 
TH activity TH activity TH phos- Protein phos- 
at pH 6.0 (Yo) at pH 7.0 (01’00) phorylation phorylation 
(total) 
Control 100 100 100 100 
+ okadaic acid 101 + 9 177 + 31 306 + 17 266 + 78 
+ okadaic acid 
(in assay only) 99 i 1 98+ 9 _ - 
TH activities were measured in the cell homogenates and are given as a percentage of those 
measured in control incubations where okadaic acid was omitted. The values are given f 
standard errors for at least six experiments performed on three preparations on 
chromaffin cells. 100% TH activity values were: 6.4 mU/mg (pH 6.0) and 1.6 mU/mg 
(pH 7.0). One unit of activity (U) is that amount which catalyses the formation of 1 pmol 
of DOPA in 1 min. TH activity and phosphorylation, and total protein phosphorylation, 
were determined as described in section 2 
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The experiments described above were carried 
out with TH phosphorylated by A-kinase. 
However, very similar results were obtained when 
TH phosphorylated predominantly in peptide C by 
the CaM-MPK was used. These experiments 
demonstrate that type 2A phosphatases are the ma- 
jor TH phosphatases in extracts of adrenal 
medulla and corpus striatum. The structure of the 
type 2A phosphatase catalytic subunit from bovine 
adrenal cortex has been deduced from the cDNA 
[24] and its structure differs at only one position 
from the rabbit skeletal muscle 2Aa isoform [25]. 
3.3. Effect of okadaic acid on the 
phosphorylation state and activity of tyrosine 
hydroxylase in bovine chromaffin cells 
Okadaic acid, a c38 polyether fatty acid [26], 
can enter cells, and when added to intact 
adipocytes or hepatocytes rapidly increases protein 
phosphorylation and alters carbohydrate and lipid 
metabolism in the manner expected of a specific 
protein phosphatase inhibitor [27]. In three dif- 
ferent batches of chromaffin cells incubated for 
90 min in the presence of 1 PM okadaic acid, total 
protein phosphorylation was increased 2.7-fold 
and TH phosphorylation 3.1-fold (table 2). In the 
same experiments, TH activity (assayed at pH 7) 
was increased 1.8-fold, while TH activity 
(measured at pH 6.0) was unaltered. Okadaic acid 
(1 PM) added directly to the assays had no effect 
on TH activity (table 2). Unphosphorylated TH 
has a pH optimum near pH 6.0, while the pH op- 
timum for the phosphorylated enzyme is higher 
[2]. Thus increased TH activity after treatment of 
the cells with okadaic acid is likely to be due to in- 
creased phosphorylation. Type 2A protein 
phosphatases have been shown to participate in a 
variety of metabolic processes [21] and the present 
work therefore extends its list of functions to in- 
clude a regulatory role in catecholamine biosyn- 
thesis. 
3.4. Conclusions 
The results described in this paper demonstrate 
that the TH phosphatases present in adrenal 
medulla and corpus striatum are accounted for by 
the phosphatase catalytic subunits present in all 
mammalian cells that have pleiotropic actions [21]. 
No evidence was found for the presence of specific 
TH phosphatases. The different peaks of TH 
phosphatase resolved by anion-exchange chroma- 
tography of rat caudate nucleus extracts [9] (a part 
of the corpus striatum) may represent different 
type 2A phosphatases in which the catalytic 
subunit is complexed to other proteins, as observed 
in other mammalian tissues (reviewed in [21]). Our 
results demonstrate that type 2A phosphatases ac- 
count for 89% and 93%, of the TH phosphatase 
activity in dilute extracts of bovine adrenal 
medulla and rabbit corpus striatum, respectively, 
at 1 mM Mg’+ and type 2C phosphatases for the 
remainder. Furthermore, the effects of okadaic 
acid on TH phosphorylation and activity in 
isolated bovine chromaffin cells indicate that type 
2A phosphatases are the major TH phosphatases 
in vivo. These observations further emphasize the 
importance of okadaic acid as a probe for identify- 
ing physiologically relevant protein phosphatases, 
and for identifying cellular processes that are 
regulated by phosphorylation. 
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